货号:A107277
同义名:
醋酸肤轻松
/ Flucort-N; NSC 92339
Fluocinolone acetonide, the acetonide form of fluocinolone, is a derivative of glucocorticoid and is used for the treatment of skin disorders.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Fluocinolone, a potent glucocorticoid receptor agonist, effectively prevents lipid accumulation and inflammation. It also promotes the proliferation of dental pulp cells (DPCs), suggesting a potential role in the repair of injured pulp tissues. Fluocinolone is being researched for its effectiveness in preventing chemotherapy-induced peripheral neuropathy, particularly associated with the use of Paclitaxel[1].[2].[3].[4]. |
Animal study | Fluocinolone (500 μg/kg, intraperitoneal injection, once daily for 2 weeks) inhibits the onset of significant peripheral neuropathy in a PTX-induced mouse model[3]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT03345914 | Dermatitis, Atopic | Phase 3 | Recruiting | April 12, 2019 | United States, Alabama ... 展开 >> Regeneron Investigational Site Recruiting Birmingham, Alabama, United States, 35209 United States, California Regneron Investigational Site Recruiting Bakersfield, California, United States, 93309 Regeneron Investigational Site Recruiting Long Beach, California, United States, 90808 Regeneron Investigational Site Recruiting Mission Viejo, California, United States, 92691 United States, Florida Regeneron Investigational Site Recruiting Coral Gables, Florida, United States, 33146 United States, Georgia Regeneron Investigational Site Recruiting Macon, Georgia, United States, 31217 Regeneron Investigational Site Recruiting Sandy Springs, Georgia, United States, 30328 United States, Maryland Regeneron Investigational Site Recruiting Rockville, Maryland, United States, 20850 United States, New York Regeneron Investigational Site Recruiting Forest Hills, New York, United States, 11375 Regeneron Investigational Site Recruiting New York, New York, United States, 10029 United States, Texas Regeneron Investigational Site Recruiting Bellaire, Texas, United States, 77401 Regeneron Investigational Site Recruiting San Antonio, Texas, United States, 78218 United States, Virginia Regeneron Investigational Site Recruiting Norfolk, Virginia, United States, 23502 Poland Regeneron Investigational Site Recruiting Białystok, Poland, 15-453 Regeneron Investigational Site Recruiting Katowice, Poland, 40-611 Regeneron Investigational Site Recruiting Katowice, Poland, 40-648 Regeneron Investigational Site Recruiting Warsaw, Poland, 01-142 Regeneron Investigational Site Recruiting Warsaw, Poland, 02-758 Regeneron Investigational Site Recruiting Warszawa, Poland, 01-817 Regeneron Investigational Site Recruiting Wrocław, Poland, 50-381 Regeneron Investigational Site Recruiting Świętokrzyskie, Poland, 27-400 收起 << |
NCT02260986 | Atopic Dermatitis | Phase 3 | Completed | - | - |
NCT01946386 | Psoriasis Vulgaris | Phase 1 | Completed | - | France ... 展开 >> CPCAD, Centre de Pharmacologie Clinique Appliquée à la Dermatologie Nice, France, 06202 收起 << |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.21mL 0.44mL 0.22mL |
11.05mL 2.21mL 1.10mL |
22.10mL 4.42mL 2.21mL |
CAS号 | 67-73-2 |
分子式 | C24H30F2O6 |
分子量 | 452.49 |
SMILES Code | O=C([C@]([C@@]1([H])C[C@@]2([H])[C@@](C[C@H](F)C3=CC4=O)([H])[C@@](F)([C@]3(C=C4)C)[C@@H](O)C5)(OC(C)(C)O1)[C@]25C)CO |
MDL No. | MFCD00010525 |
别名 | 醋酸肤轻松 ;Flucort-N; NSC 92339; Fluocinolone(Acetonide) |
运输 | 蓝冰 |
InChI Key | FEBLZLNTKCEFIT-VSXGLTOVSA-N |
Pubchem ID | 6215 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Inert atmosphere, 2-8°C |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 |
IP 2% DMSO+2% Tween80+30% PEG300+water 8 mg/mL clear PO 0.5% CMC-Na 30 mg/mL suspension |